Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Compounding Oversight: What Price Safety?

Oct 15 2012

• By Martin Berman-Gorvine

Related Content

Dusa Patent Suit Challenges Compounding Of Levulan

Dec 28 2004

Avastin-Related Eye Infections Could Bring FDA Pressure On Compounding Pharmacies

Aug 31 2011

FDA Guidance Policy Could Be Hurt By Ruling On Animal Drug Compounding

Sep 26 2011

Supreme Court Reaffirms Least Restrictive Standard For Ad Controls

May 06 2002

Compounded Drugs May Return To Supreme Court After 5th Circuit Backs FDAMA

Aug 18 2008

Related Companies

DUSA Pharmaceuticals, Inc.

Genentech, Inc.

Roche Holding AG

Additional Topics

United States Safety Recalls BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window